iifl-logo-icon 1

Parmax Pharma Ltd Cash Flow Statement

42
(0.48%)
Feb 19, 2025|01:12:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Parmax Pharma FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2020Mar-2018Mar-2017Mar-2016

Profit before tax

0.73

0

0

0.01

Depreciation

-1

-1.09

0

0

Tax paid

-0.3

0

-0.01

-0.01

Working capital

-0.24

-2.57

0.01

Other operating items

Operating

-0.81

-3.66

0

Capital expenditure

2.68

4.23

0.2

Free cash flow

1.86

0.56

0.2

Equity raised

0.29

0.2

0.21

Investing

0.2

0

0

Financing

7.22

2.98

1.48

Dividends paid

0

0

0

0

Net in cash

9.57

3.75

1.9

Parmax Pharma : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.